438 related articles for article (PubMed ID: 32708794)
1. The Role of MicroRNAs in Repair Processes in Multiple Sclerosis.
Duffy CP; McCoy CE
Cells; 2020 Jul; 9(7):. PubMed ID: 32708794
[TBL] [Abstract][Full Text] [Related]
2. Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis.
Rodriguez M
Brain Pathol; 2007 Apr; 17(2):219-29. PubMed ID: 17388953
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis.
Thamilarasan M; Koczan D; Hecker M; Paap B; Zettl UK
Autoimmun Rev; 2012 Jan; 11(3):174-9. PubMed ID: 21621006
[TBL] [Abstract][Full Text] [Related]
4. miR-219 Cooperates with miR-338 in Myelination and Promotes Myelin Repair in the CNS.
Wang H; Moyano AL; Ma Z; Deng Y; Lin Y; Zhao C; Zhang L; Jiang M; He X; Ma Z; Lu F; Xin M; Zhou W; Yoon SO; Bongarzone ER; Lu QR
Dev Cell; 2017 Mar; 40(6):566-582.e5. PubMed ID: 28350989
[TBL] [Abstract][Full Text] [Related]
5. Stem Cell-Derived Exosomal MicroRNAs as Novel Potential Approach for Multiple Sclerosis Treatment.
Tahmasebi F; Asl ER; Vahidinia Z; Barati S
Cell Mol Neurobiol; 2024 May; 44(1):44. PubMed ID: 38713302
[TBL] [Abstract][Full Text] [Related]
6. Remyelination in multiple sclerosis: realizing a long-standing challenge.
Aharoni R
Expert Rev Neurother; 2015; 15(12):1369-72. PubMed ID: 26558886
[TBL] [Abstract][Full Text] [Related]
7. Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: A comprehensive overview.
Piket E; Zheleznyakova GY; Kular L; Jagodic M
J Autoimmun; 2019 Jul; 101():17-25. PubMed ID: 31014917
[TBL] [Abstract][Full Text] [Related]
8. [MiRNAs: new actors in the physiopathology of multiple sclerosis].
Jagot F; Davoust N
Med Sci (Paris); 2017; 33(6-7):620-628. PubMed ID: 28990564
[TBL] [Abstract][Full Text] [Related]
9. miRNAs Participate in MS Pathological Processes and Its Therapeutic Response.
Wu T; Chen G
Mediators Inflamm; 2016; 2016():4578230. PubMed ID: 27073296
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated Network of miRNAs Involved in the Pathogenesis of Multiple Sclerosis.
Dolati S; Marofi F; Babaloo Z; Aghebati-Maleki L; Roshangar L; Ahmadi M; Rikhtegar R; Yousefi M
Biomed Pharmacother; 2018 Aug; 104():280-290. PubMed ID: 29775896
[TBL] [Abstract][Full Text] [Related]
11. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
Olsen JA; Akirav EM
J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
[TBL] [Abstract][Full Text] [Related]
12. miRNAs in Microglia: Important Players in Multiple Sclerosis Pathology.
Walsh AD; Nguyen LT; Binder MD
ASN Neuro; 2021; 13():1759091420981182. PubMed ID: 33517686
[TBL] [Abstract][Full Text] [Related]
13. Multiple Sclerosis: Basic and Clinical.
Buzzard K; Chan WH; Kilpatrick T; Murray S
Adv Neurobiol; 2017; 15():211-252. PubMed ID: 28674983
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS).
KhorshidAhmad T; Acosta C; Cortes C; Lakowski TM; Gangadaran S; Namaka M
Mol Neurobiol; 2016 Mar; 53(2):1092-1107. PubMed ID: 25579386
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs associated with the pathogenesis of multiple sclerosis.
Huang Q; Xiao B; Ma X; Qu M; Li Y; Nagarkatti P; Nagarkatti M; Zhou J
J Neuroimmunol; 2016 Jun; 295-296():148-61. PubMed ID: 27235360
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA in multiple sclerosis.
Gao Y; Han D; Feng J
Clin Chim Acta; 2021 May; 516():92-99. PubMed ID: 33545109
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria in Multiple Sclerosis: Molecular Mechanisms of Pathogenesis.
Patergnani S; Fossati V; Bonora M; Giorgi C; Marchi S; Missiroli S; Rusielewicz T; Wieckowski MR; Pinton P
Int Rev Cell Mol Biol; 2017; 328():49-103. PubMed ID: 28069137
[TBL] [Abstract][Full Text] [Related]
18. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
[TBL] [Abstract][Full Text] [Related]
19. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
Zhang Y; Li X; Ciric B; Curtis MT; Chen WJ; Rostami A; Zhang GX
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9082-9093. PubMed ID: 32253301
[TBL] [Abstract][Full Text] [Related]
20. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
Gonçalves ED; Souza PS; Lieberknecht V; Fidelis GS; Barbosa RI; Silveira PC; de Pinho RA; Dutra RC
Autoimmunity; 2016; 49(2):132-42. PubMed ID: 26703077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
